New device technologies allow for detection of clinically silent atrial fibrillation. This new entity has been associated with increased risk for stroke, even if detected for only relatively brief time periods. Current practice guidelines do not provide recommendations on how to approach this new clinical entity.
|Original language||English (US)|
|Number of pages||2|
|Journal||Journal of Electrocardiology|
|State||Published - Nov 1 2016|
- Subclinical atrial fibrillation
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine